Research & Development
Scleroderma treatment by Certa Therapeutics granted US FDA fast track
FT011 is a novel, first-in-class oral therapy for the treatment of chronic fibrosis in multiple organs
Indian government bans three medicines owing to health risks
Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
Optimising bioprocess skid functionality with low shear, low pulsation pumps
CPi Biotech makes use of a range of peristaltic pumps from Watson-Marlow Fluid Technology Solutions (WMFTS) to ensure that its skid platforms provide major multinational...
Does CBD really harm the liver?
With the exception of certain approved drugs such, as Epidiolex and Sativex, the US Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA) have voiced...
How to avoid sticking and picking in the tableting industry
John Norman and Kevin Queensen of Natoli Engineering explain
Pharma Sustainability Integrates
28 February 2024 | Conference | London, UK
DFE Pharma opens Indian OSD-focused pharma support centre
The company has planned to provide services that are mainly focus on oral solid dosage (OSD) forms and comprise a range of pre-registration work including development, scale-up, and technology transfer
DFE Pharma expands its inhalation portfolio with the launch of Lactohale 400
Being a leader in dry powder inhalation, DFE Pharma further expands its broad excipient portfolio of inhalation grade lactose
DFE Pharma opens its new centre of excellence in India to provide fast-track formulation services
The new Closer to the Formulator (C2F) centre offers DFE Pharma’s excipient expertise to help pharmaceutical companies achieve right-first-time formulations
Manufacturing Chemist LIVE 2022 in review (part I)
Taking a front row seat during the two-day pharmaceutical conference in Birmingham, UK, Dr Kevin Robinson reports on what’s new, emerging and exciting in the world of drug delivery and beyond
Manufacturing Chemist LIVE announces NEPIC as an event partner
NEPIC members are invited to attend or exhibit at this year's event at a discounted rate.
DFE Pharma appoints Chief Executive Officer
Martti Hedman joins from Colorcon, where he was also CEO
DMV-Fonterra to buy Brahmar Cellulose Private Limited
Provides a strong base for future developments